- Patent Title: Composition comprising HMOs for preventing or reducing nociception
-
Application No.: US16956511Application Date: 2018-12-19
-
Publication No.: US11304966B2Publication Date: 2022-04-19
- Inventor: Bruce McConnell , Louise Kristine Vigsnæs , Sami Damak , Norbert Sprenger , Francis Foata
- Applicant: Glycom A/S
- Applicant Address: DK Hørsholm
- Assignee: Glycom A/S
- Current Assignee: Glycom A/S
- Current Assignee Address: DK Hørsholm
- Agency: Kunzler Bean & Adamson
- Priority: DKPA201700740 20171222
- International Application: PCT/IB2018/060344 WO 20181219
- International Announcement: WO2019/123316 WO 20190627
- Main IPC: A61K31/702
- IPC: A61K31/702 ; A61P1/00 ; A61K31/7016
Abstract:
The application relates to synthetic compositions and methods for preventing or reducing nociception and/or nociceptive sensitivity in a non-infant human. The human is administered a composition comprising 6′-sialyllactose (6′-SL) and/or lacto-N-tetraose (LNT).
Public/Granted literature
- US20210008087A1 COMPOSITION COMPRISING HMOs FOR PREVENTING OR REDUCING NOCICEPTION Public/Granted day:2021-01-14
Information query
